Lataa...
Confused Connections? Targeting White Matter to Address Treatment Resistant Schizophrenia
Despite development of comprehensive approaches to treat schizophrenia and other psychotic disorders and improve outcomes, there remains a proportion (approximately one-third) of patients who are treatment resistant and will not have remission of psychotic symptoms despite adequate trials of pharmac...
Tallennettuna:
| Julkaisussa: | Front Pharmacol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6201564/ https://ncbi.nlm.nih.gov/pubmed/30405407 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2018.01172 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|